Search
Menu
PI Physik Instrumente - Revolution In Photonics Align ROSLB 3/24

Daily News Briefs

Facebook X LinkedIn Email
Corning Inc. has been granted a license for patent rights to reverse transfection method technology for the drug discovery research market by the Whitehead Institute for Biomedical Research, through Massachusetts Institute of Technology (MIT), its licensing agent. Corning will use the intellectual property with fundamental technology it previously licensed from Aastrom Biosciences Inc. to enhance the development of its molecular and cell culture applications. Corning holds exclusive rights to Aastrom's surface-mediated cell transfection technology, used to increase the frequency and efficiency of introducing foreign genes into cells.

DataRay Inc. - ISO 11146-Compliant

Published: August 2005
BiophotonicsCorningMassachusetts Institute of TechnologyNews BriefsPhotonics Tech BriefsWhitehead Institute for Biomedical Research

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.